摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-Cyano-phenyl)-thiazole-5-carboxylic acid ethyl ester | 344416-78-0

中文名称
——
中文别名
——
英文名称
4-(3-Cyano-phenyl)-thiazole-5-carboxylic acid ethyl ester
英文别名
Ethyl 4-(3-cyanophenyl)-1,3-thiazole-5-carboxylate
4-(3-Cyano-phenyl)-thiazole-5-carboxylic acid ethyl ester化学式
CAS
344416-78-0
化学式
C13H10N2O2S
mdl
——
分子量
258.301
InChiKey
IQQXIGIATRUNCH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    450.8±40.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    91.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core
    摘要:
    The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted heterocyclic core. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00029-4
  • 作为产物:
    参考文献:
    名称:
    Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core
    摘要:
    The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted heterocyclic core. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00029-4
点击查看最新优质反应信息

文献信息

  • OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
    申请人:Bristol-Myers Squibb Pharma Company
    公开号:EP0946528B1
    公开(公告)日:2003-04-09
  • Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors
    申请人:——
    公开号:US20040073029A1
    公开(公告)日:2004-04-15
    The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(═NH)NH 2 , which are useful as inhibitors of factor Xa.
  • US6187797B1
    申请人:——
    公开号:US6187797B1
    公开(公告)日:2001-02-13
  • US6569874B1
    申请人:——
    公开号:US6569874B1
    公开(公告)日:2003-05-27
  • US6962935B2
    申请人:——
    公开号:US6962935B2
    公开(公告)日:2005-11-08
查看更多